阻害性受容体はANGPTLsと結合し,血液幹細胞と白血病の発症をサポートします
Junke Zheng1, Masato Umikawa, Changhao Cui
1Departments of Physiology and Developmental Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Nature
|June 5, 2012
まとめ
免疫抑制受容体,ヒト白血球免疫グロブリン型受容体B2 (LILRB2) とペア型免疫グロブリン型受容体 (PIRB) は,アニオポエチン型タンパク質 (ANGPTLs) に結合する. この相互作用は,成人の幹細胞の活性と白血病の発症をサポートします.
科学分野:
- 細胞生物学 細胞生物学
- 免疫学 免疫学とは
- 血液学 ヘマトロジ
背景:
- 表面受容体経由の環境信号による成体幹細胞と癌細胞の活性化の調節は十分に理解されていません.
- アンジオポエチン型のタンパク質 (ANGPTLs) は,血液生成幹細胞 (HSC) の活動をサポートすることが知られているが,特定された受容体がないため,孤児リガンドとみなされた.
- ANGPTLは,脂質代謝,血管新生,炎症にも役割を果たします.
研究 の 目的:
- アンジオポエチン型タンパク質 (ANGPTLs) の受容体を特定する.
- 大人の幹細胞の維持と癌の発生におけるこれらの受容体の役割を調査する.
主な方法:
- バイオケミカルとセルラーアッセイを用いて,ANGPTLsの受容体としてLILRB2とPIRBの識別.
- LILRB2とPIRBの発現をヒトとマウスのHSCで分析した.
- LILRB2/PIRBへのANGPTL結合の評価と,HSC拡張に対するその影響について.
- マウスの急性骨髄性白血病モデルにおけるPIRB信号伝達の役割の評価.
主要な成果:
- ヒト白血球免疫グロブリン型受容体B2 (LILRB2) とそのマウス・オートログのペア免疫グロブリン型受容体 (PIRB) は,いくつかのANGPTLsの受容体として特定されました.
- LILRB2とPIRBへのANGPTL結合は,HSCのエクスビボ拡張を支えた.
- マウスにおける急性骨髄性白血病のモデルにおけるPIRB細胞内信号伝達の欠乏は,白血病細胞の分化の増加につながり,PIRBが白血病の発達をサポートすることを示しています.
結論:
- 古典的な免疫抑制受容体であるLILRB2とPIRBは,正常な成人の幹細胞の幹性を維持するために意外に機能します.
- これらの受容体は,特に急性骨髄性白血病において,がんの発症を支援する役割も果たしています.
関連する概念動画
Enzyme-linked Receptors
64.6K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
64.6K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Regulation of Hematopoietic Stem Cells
3.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Transducer Mechanism: Enzyme-Linked Receptors
4.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.4K


